C60 Truth: Nano Technology & Cancer with Ian Mitchell

Ian Mitchell, Chief Scientist of Live Pet, joins the program to discuss the huge breakthroughs they are making with C60 and cancer. He also discusses the fears surrounding C60 and nano technology. He explains the science and clears many misconceptions. We also discuss the potential of C60 as a base for many protocols that will revolutionize the world of medicine and health. Consider supporting the show and see exclusive interview content with Ian Mitchell and many other guests at https://www.patreon.com/SarahWestall Important Information share in the show Turn your body into a FAT BURNING MACHINE! Link to the FREE Keto Summit (May 7 - 13) - http://healthaffiliate.center/22852-28.html Sign up for the free Home Medicine Summit at http://ddddddd.ontraport.com/t?orid=239638&opid=213 Requirements to Participate in the Cancer Trial: 1) The pet owners need to be willing to have the type of cancer identified by their vet if they don't already know what type it is. 2) They need to be willing to use a holistic treatment regimen which will include modifying the dogs diet for a period of 6-8 weeks. 3) During this period they will have to be willing to have the vet take pictures/images of the cancers and provide all data to LivePet so we can assess everything and make adjustments as necessary. 4) Also, they will need to be super cool and really love their dogs!! :) 5) If your loved pet fit the above criteria contact Ian and his team at stopcancer@livepetllc.com Information from the show: This is a link to the research that Johns Hopkins released last year that showed how they manipulated systems of communication using IL-6 and IL-8 and slowed down metastasis. The main thing really jumped out at me is that they point out that 90% of all cancer deaths are from metastasis. http://releases.jhu.edu/2017/05/26/new-cellular-target-may-put-the-brakes-on-cancers-ability-to-spread/ http://www.nature.com/articles/ncomms15584 Next is the link to the article showing how you have to effect mitochondrial function in order for the cancer to spread. http://www.cell.com/cell-reports/fulltext/S2211-1247(14)00527-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124714005270%3Fshowall%3Dtrue And the last of the articles is the one Duke released last week about how cancer gorges on fructose in the liver. This is the reason behind the dietary restrictions in our protocol. https://www.sciencedaily.com/releases/2018/04/180426141533.htm Ian Mitchell Biography Ian Mitchell is firmly planted in the biomedical and interface technology spaces. Formerly at M&M Biomedical, he was involved in developing multiple products focused on the intersection of mobile telecommunications and biomedical engineering. He was a project lead on the corporate team designing and developing microfluidic multi-assay systems for use with Lab-on-Chip (LoC) devices. Additionally he has acted as a fabrication consultant for NASA’s “ENDURANCE mission” project is versed in the use of CAD systems for engineering design, and have two decades of experience managing projects across multiple industries and has developed a novel catalytic process for the conjugation of C60 nanoparticulate. . See the full interview on YouTube: https://youtu.be/hPEDJAd2rVA See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.